- Patients treated with Torisel (patients with metastatic and/or radically unresectable
or advanced renal cell carcinoma).
- Among patients registered and treated in the Special Investigation, All-case Survey of
Torisel, those continuously treated with Torisel for more than 24 weeks will be
- Patients not administered Torisel.
- Patients with a history of severe hypersensitivity to temsirolimus, sirolimus
derivative, or any of their components and/or derivatives.